Literature DB >> 18077304

The cost-effectiveness and cost-benefit of screening and brief intervention for unhealthy alcohol use in medical settings.

Kevin L Kraemer1.   

Abstract

Economic evaluation can be a valuable tool for assessing the efficiency and value of health care programs. To examine the literature on the economic evaluation of alcohol screening and brief intervention in medical settings, relevant studies were identified in the MEDLINE database (1966 through November 2006) and by hand-searching the references of identified articles and relevant journals. The 15 identified studies used a range of economic evaluation methods, including cost analysis, cost-benefit, cost-effectiveness, and cost-utility. Nearly all of the studies supported the use of alcohol screening and brief intervention. The studies that prospectively collected cost and effect data and/or conformed closely to methodological guidelines demonstrated a strong economic benefit of alcohol screening and brief intervention when compared to usual care. Overall, the reviewed studies support alcohol SBI in medical settings as a wise use of health care resources and illustrate the usefulness of economic evaluation for assessing alcohol prevention and treatment programs.

Entities:  

Mesh:

Year:  2007        PMID: 18077304     DOI: 10.1300/J465v28n03_07

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  14 in total

Review 1.  Screening and brief intervention for underage drinkers.

Authors:  Duncan B Clark; Adam J Gordon; Lorraine R Ettaro; Jill M Owens; Howard B Moss
Journal:  Mayo Clin Proc       Date:  2010-04       Impact factor: 7.616

2.  The Impact of a Mandated Trauma Center Alcohol Intervention on Readmission and Cost per Readmission in Arizona.

Authors:  Jesse M Hinde; Jeremy W Bray; Arnie Aldridge; Gary A Zarkin
Journal:  Med Care       Date:  2015-07       Impact factor: 2.983

3.  Together Achieving More: Primary Care Team Communication and Alcohol-Related Healthcare Utilization and Costs.

Authors:  Marlon P Mundt; Larissa I Zakletskaia; David A Shoham; Wen-Jan Tuan; Pascale Carayon
Journal:  Alcohol Clin Exp Res       Date:  2015-09-09       Impact factor: 3.455

Review 4.  A systematic review and meta-analysis of health care utilization outcomes in alcohol screening and brief intervention trials.

Authors:  Jeremy W Bray; Alexander J Cowell; Jesse M Hinde
Journal:  Med Care       Date:  2011-03       Impact factor: 2.983

5.  Study designs and evaluation models for emergency department public health research.

Authors:  Kerry B Broderick; Megan L Ranney; Federico E Vaca; Gail D'Onofrio; Richard E Rothman; Karin V Rhodes; Bruce Becker; Jason S Haukoos
Journal:  Acad Emerg Med       Date:  2009-11       Impact factor: 3.451

6.  The association between intimate partner violence, alcohol and depression in family practice.

Authors:  Gail Gilchrist; Kelsey Hegarty; Patty Chondros; Helen Herrman; Jane Gunn
Journal:  BMC Fam Pract       Date:  2010-09-27       Impact factor: 2.497

Review 7.  The estimation of utility weights in cost-utility analysis for mental disorders: a systematic review.

Authors:  Michael Sonntag; Hans-Helmut König; Alexander Konnopka
Journal:  Pharmacoeconomics       Date:  2013-12       Impact factor: 4.981

Review 8.  A literature review of cost-benefit analyses for the treatment of alcohol dependence.

Authors:  Svetlana Popova; Satya Mohapatra; Jayadeep Patra; Amy Duhig; Jürgen Rehm
Journal:  Int J Environ Res Public Health       Date:  2011-08-16       Impact factor: 3.390

9.  Cost-effectiveness of an opportunistic screening programme and brief intervention for excessive alcohol use in primary care.

Authors:  Luqman Tariq; Matthijs van den Berg; Rudolf T Hoogenveen; Pieter H M van Baal
Journal:  PLoS One       Date:  2009-05-27       Impact factor: 3.240

10.  Grand challenges: Improving HIV treatment outcomes by integrating interventions for co-morbid mental illness.

Authors:  Sylvia Kaaya; Eddy Eustache; Ilana Lapidos-Salaiz; Seggane Musisi; Christina Psaros; Lawrence Wissow
Journal:  PLoS Med       Date:  2013-05-21       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.